You are currently viewing a new version of our website. To view the old version click .
Current Oncology
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
  • Article
  • Open Access

1 October 2013

Colorectal Cancer Screening in Canada: Results from the First Round of Screening for Five Provincial Programs

,
,
,
,
,
,
,
and
on behalf of the Colorectal Cancer Screening Monitoring Program Performance Working Group and the Canadian Partnership Against Cancer
1
Screening and Early Detection Portfolio, Canadian Partnership Against Cancer, Toronto, ON, Canada
2
Cancer Control Division, Canadian Partnership Against Cancer, Toronto, ON, Canada
3
Chronic Disease Prevention and Management Unit, Health PEI, Charlottetown, PE, Canada
4
Cancer Screening, BC Cancer Agency, Vancouver, BC, Canada

Abstract

Background: Early implementation of programmatic colorectal cancer (CRC) screening for average-risk individuals 50–74 years of age in Canada has used fecal occult blood tests [FTS (guaiac or immunochemical)] and colonoscopy for follow-up of abnormal FTS. This paper presents results of an evaluation of this CRC screening. Methods: Five Canadian provincial programs provided aggregated data for individuals with a first-round FT processed between January 1, 2009, and December 31, 2011. Results: The 104,750 people who successfully completed a first round of screening represented 16.1% of those who had access to the programs between January 1, 2009, and December 31, 2011 (mean age: 61.2 years; men: 61.4 years; women: 61.1 years). Of those participants, 4661 had an abnormal FT (4.4%). Uptake of colonoscopy within 180 days after an abnormal FT was 80.5%, ranging from 67.8% to 89.5% by program. The positive predictive value (PPV) for adenoma was 35.9% for guaiac FT and 50.6% for immunochemical FT. Adenoma and CRC detection rates were, respectively, 16.9 and 1.8 per 1000 screened. Of invasive crcs detected, 64.6% were stage I or II. Conclusions: Considering the variation in characteristics and stage of implementation of each provincial program, the collaboration of the provinces leading to this report on the early performance of CRC screening in Canada is a major milestone. Targets are met or nearly met for significant indicators such as PPV for adenoma and cancer detection rate. Participation is expected to increase as programs are fully implemented in the provinces. Additional effort may be needed to improve timely access to follow-up colonoscopy.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.